BioSpace News Archive

CURE Pharmaceutical Holding Corp. (OTC: CURR), a technology-focused, vertically integrated drug delivery and product development company in the pharmaceutical and health & wellness space, announced today that the Company’s Chief Executive Officer Rob Davidson will be presenting virtually at NobleCon17, Noble Capital Markets’ Seventeenth Annual Institutional Investor Conference,

Masimo (NASDAQ: MASI) today announced the global launch of iSirona ™ , a compact, versatile connectivity hub designed to maximize interoperability across the continuum of care. The iSirona hub offers an efficient way to physically connect up to six medical devices at the bedside and automatically route the data to the Masimo Hospital Automation ™ platform, a vendor-agnost

RenovaCare, Inc. (Symbol: RCAR; www.renovacareinc.com ), a clinical-stage developer of patented technologies for spraying self-donated stem cells for the regeneration of skin and other organs and tissues, announced today that the Company will present at NobleCon17 – Noble Capital Markets’ Seventeenth Annual Investor Conference on Tuesday, January 19 at 5:15pm EST. The conference is virtual, with no cost, obligation or restrictions to attend:

Sun Nuclear Corporation announced that Ogaki Municipal Hospital has selected a collection of Sun Nuclear solutions for its end-to-end Radiation Therapy Quality Assurance program.

Veteran physician executive Mimi Huizinga brings a deep understanding of the role novel data plays in treatment development and delivery

OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”) today announced it entered into an agreement with Sirtex Medical, Inc. (Sirtex) granting Sirtex an option to non-exclusively co-promote the Company’s lead product candidate, TAVO™ (tavokinogene telseplasmid) in anti-PD-1 checkpoint refractory metastatic melanoma in the U.S.

Omeros Corporation (Nasdaq: OMER) announced today that the Biologics License Application (BLA) for narsoplimab for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) has been accepted for filing by the U.S. Food and Drug Administration (FDA)

Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of Peripheral Artery Disease (PAD), today provided an update on the expansion of its intellectual property portfolio in 2020.

Icentia Inc., a leading Canadian technology company—specialised in cardiac ambulatory monitoring—will be providing a new home-based service nationwide that will enable patients with heart rhythm disorders to have access to an ambulatory cardiac test from the safety of their homes while the pandemic surges on.

Sirtex Medical US Holdings, Inc. (“Sirtex”), a leading manufacturer of targeted cancer therapies, announced an advancement in its strategic collaboration with OncoSec Medical, Inc. (NASDAQ: ONCS) relating to OncoSec’s lead product candidate TAVO™ (tavokinogene telseplasmid) and its electroporation (EP) gene delivery system.